Xalkori
Payments companies reported to CMS as associated with Xalkori. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xalkori, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xalkori
These are the largest totals companies reported as associated with Xalkori. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alice Shaw | Boston, MA | Internal Medicine | $10,700.00 |
| Puneeth Iyengar | Dallas, TX | Radiation Oncology | $6,200.00 |
| Martin Dietrich | Rockledge, FL | Hematology & Oncology | $3,749.37 |
| Elizabeth Castronovo | Boston, MA | Adult Health (Nurse Practitioner) | $3,700.00 |
| Elizabeth Krueger | Boston, MA | Family | $3,700.00 |
| Nathan Pennell | Cleveland, OH | Hematology & Oncology | $3,700.00 |
| Mary Grizzard | Franklin, TN | Family | $3,700.00 |
| Courtney Oshiro | Douglasville, GA | Medical | $3,700.00 |
| Stephanie Mcdonald | Boston, MA | Nurse Practitioner | $3,700.00 |
| Michael Cheng | Orange, CA | Rheumatology | $3,700.00 |
Prescribed Xalkori?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.